Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: involvement of eicosanoids.
Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model.
Electromagnetic Field Stimulation Potentiates Endogenous Myelin Repair by Recruiting Subventricular Neural Stem Cells in an Experimental Model of White Matter Demyelination.
Accidental natalizumab administration in pregnancy in multiple sclerosis.
Can PET imaging tell us what's the matter with the gray matter in multiple sclerosis?
Extreme Stability of Chitotriosidase in Cerebrospinal Flulid makes it a Suitable Marker for Microglial Activation in Clinical Trials.
Cerebellar-parietal dysfunctions in multiple sclerosis patients with cerebellar signs.
Tract-based spatial statistics analysis of diffusion-tensor imaging data in pediatric- and adult-onset multiple sclerosis.
Disease progression in chronic relapsing experimental allergic encephalomyelitis is associated with reduced inflammation-driven production of corticosterone.
Is the treatment of multiple sclerosis headed in the wrong direction?
Analysis of T2 intensity by magnetic resonance imaging of deep gray matter nuclei in multiple sclerosis patients: effect of immunomodulatory therapies.
Effects of Topiramate on Dysaesthetic Pain in a Patient with Multiple Sclerosis.
Animal assisted interventions in neurorehabilitation: A review of the most recent literature.
The benefits and detriments of macrophages/microglia in models of multiple sclerosis.
Combined treatment with atorvastatin and minocycline suppresses severity of EAE.
A Novel MicroRNA-132-Surtuin-1 Axis Underlies Aberrant B-cell Cytokine Regulation in Patients with Relapsing-Remitting Multiple Sclerosis.
Simvastatin regulates oligodendroglial process dynamics and survival.
B-50Alternate Scoring of the Paced Auditory Serial Addition Test (PASAT): Evaluating Strings of Consecutive Correct Responses as Predictors of Cognitive Functioning in Patients with Multiple Sclerosis.
European Medicines Agency Validates Marketing Authorisation Application for ZINBRYTA™ (Daclizumab High-Yield Process) for Treatment of MS
Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial.
The recurrent Guillain-Barré syndrome: a long-term population-based study.
Surveillance and medical therapy following endovascular treatment of chronic cerebrospinal venous insufficiency.
A Randomized Controlled Trial of Cognitive Behavioral Therapy (CBT) for Adjusting to Multiple Sclerosis (the saMS Trial): Does CBT Work and for Whom Does It Work?
Validation and interpretation of the Dutch version of the Multiple Sclerosis Neuropsychological Screening Questionnaire.

Pages